These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10844092)

  • 1. Non-steroidal anti-inflammatory drugs and apoptosis in the gastrointestinal tract: potential role of the pentose phosphate pathways.
    Porter SN; Howarth GS; Butler RN
    Eur J Pharmacol; 2000 May; 397(1):1-9. PubMed ID: 10844092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.
    Wallace JL
    Can J Physiol Pharmacol; 1994 Dec; 72(12):1493-8. PubMed ID: 7736340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs: how do they damage the gut?
    Levi S; Shaw-Smith C
    Br J Rheumatol; 1994 Jul; 33(7):605-12. PubMed ID: 8019787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract.
    Bjarnason I; Thjodleifsson B
    Rheumatology (Oxford); 1999 May; 38 Suppl 1():24-32. PubMed ID: 10369403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.
    Dial EJ; Doyen JR; Lichtenberger LM
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of non-steroidal antirheumatic agents on the gastrointestinal tract: clinical aspects and pathophysiology].
    Bertschinger P; Zala GF; Fried M
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1566-8. PubMed ID: 8927960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
    Vogiagis D; Brown W; Glare EM; O'Brien PE
    Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective cyclooxygenase-2 inhibitors and the digestive tract].
    Chaabouni H; Amouri A; Cheikh I; Kchaou M; Ouerghi H; Ben Mami N; Ben Ammar A
    Tunis Med; 2002 Aug; 80(8):427-33. PubMed ID: 12703120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of NSAIDs. An assault on the upper gastrointestinal tract.
    Heigh RI
    Postgrad Med; 1994 Nov; 96(6):63-8. PubMed ID: 7971613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of nonsteroidal anti-inflammatory drugs.
    Tenenbaum J
    Can J Gastroenterol; 1999 Mar; 13(2):119-22. PubMed ID: 10203429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast®) on colon adenocarcinoma (HT29) cells in vitro.
    Bonaterra GA; Kelber O; Weiser D; Kinscherf R
    Phytomedicine; 2013 Jun; 20(8-9):691-8. PubMed ID: 23535188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-releasing NSAIDs: a review of their current status.
    Fiorucci S; Antonelli E; Burgaud JL; Morelli A
    Drug Saf; 2001; 24(11):801-11. PubMed ID: 11665868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.
    Dai Y; Wang WH
    World J Gastroenterol; 2006 May; 12(18):2884-9. PubMed ID: 16718813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.